Mckesson Corp
NYSE:MCK

Watchlist Manager
Mckesson Corp Logo
Mckesson Corp
NYSE:MCK
Watchlist
Price: 610.84 USD -1.15%
Market Cap: 77.5B USD
Have any thoughts about
Mckesson Corp?
Write Note

Mckesson Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mckesson Corp
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Mckesson Corp
NYSE:MCK
Revenue
$330.2B
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
8%
Cardinal Health Inc
NYSE:CAH
Revenue
$224.3B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
9%
Henry Schein Inc
NASDAQ:HSIC
Revenue
$12.5B
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
2%
Adapthealth Corp
NASDAQ:AHCO
Revenue
$4.1B
CAGR 3-Years
25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Patterson Companies Inc
NASDAQ:PDCO
Revenue
$6.5B
CAGR 3-Years
1%
CAGR 5-Years
3%
CAGR 10-Years
6%
Cencora Inc
NYSE:COR
Revenue
$294B
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
9%
No Stocks Found

Mckesson Corp
Revenue Breakdown

Breakdown by Geography
Mckesson Corp

Not Available

Breakdown by Segments
Mckesson Corp

Total Revenue: 309B USD
100%
United States Pharmaceutical: 278.7B USD
90.2%
International: 14.1B USD
4.6%
Medical-Surgical Solutions: 11.3B USD
3.7%
Prescription Technology Solutions: 4.8B USD
1.5%
Show More
Show Less

Mckesson Corp
Glance View

Market Cap
77.6B USD
Industry
Health Care
Economic Moat
Narrow

McKesson Corporation stands as a cornerstone of the healthcare industry, playing a vital role in the distribution and management of pharmaceuticals and healthcare services. Founded in 1833, the company has evolved from its early days as a drug wholesaler into a formidable player providing critical support in the supply chain for hospitals, pharmacies, and healthcare providers across the United States and beyond. With a strong commitment to enhancing patient care, McKesson offers a comprehensive range of services, including the distribution of prescription medications, health information technology, and pharmacy management. This diverse portfolio not only strengthens the company’s market position but also underscores its commitment to improving healthcare outcomes. For investors, McKesson represents both a growth opportunity and a stable investment in the ever-evolving healthcare landscape. The company's robust revenue streams, driven by increasing demand for pharmaceuticals and innovative healthcare solutions, position it favorably for long-term growth, especially in light of the ongoing transformations in healthcare delivery. Furthermore, McKesson's strategic partnerships and acquisitions amplify its capabilities, enabling it to tackle emerging market trends. With a history of resilience and adaptation, McKesson is well-positioned to navigate challenges in the healthcare sector, making it an attractive proposition for those seeking a reliable investment in a vital industry.

MCK Intrinsic Value
1 055.93 USD
Undervaluation 42%
Intrinsic Value
Price

See Also

What is Mckesson Corp's Revenue?
Revenue
330.2B USD

Based on the financial report for Sep 30, 2024, Mckesson Corp's Revenue amounts to 330.2B USD.

What is Mckesson Corp's Revenue growth rate?
Revenue CAGR 10Y
8%

Over the last year, the Revenue growth was 13%. The average annual Revenue growth rates for Mckesson Corp have been 10% over the past three years , 8% over the past five years , and 8% over the past ten years .

Back to Top